John Hairston

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer

Neal D. Shore, Joseph Renzulli, Neil Fleshner et al. · JAMA Oncology · 2022 · 57 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

Steven A. Kaplan, Sender Herschorn, Kevin T. McVary et al. · The Journal of Urology · 2020 · 52 citations

Medicine, Pharmacotherapy, Urology +16

Diagnostic discordance of electromyography (EMG) versus voiding cystourethrogram (VCUG) for detrusor‐external sphincter dyssynergy (DESD)

Elise De, Chirag Y. Patel, Brenda Tharian et al. · Neurourology and Urodynamics · 2005 · 46 citations

Medicine, Neurology, Urology +17

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study

Riad Salem, John Hairston, Elias Hohlastos et al. · Urology · 2018 · 46 citations

Medicine, Surgery, Urology +10

A NOVEL ENDOSCOPIC APPROACH TOWARDS RESECTION OF THE DISTAL URETER WITH SURROUNDING BLADDER CUFF DURING HAND ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY

Chris M. Gonzalez, Robert A. Batler, Richard A. Schoor et al. · The Journal of Urology · 2001 · 45 citations

Medicine, Surgery, Urology +17